B-Symptom	0	6	Threat
I-Symptom	7	9	to
I-Symptom	10	18	fixation
O	19	21	at
O	22	31	diagnosis
O	32	35	and
O	36	44	lifetime
O	45	49	risk
O	50	52	of
B-Symptom	53	59	visual
I-Symptom	60	70	impairment
O	71	73	in
B-Disease	74	78	open
I-Disease	78	79	-
I-Disease	79	84	angle
I-Disease	85	93	glaucoma
O	93	94	.

O	96	98	To
O	99	110	investigate
O	111	118	whether
B-Symptom	119	125	threat
I-Symptom	126	128	to
I-Symptom	129	137	fixation
O	138	139	(
B-Symptom	139	142	TTF
O	142	143	)
O	144	146	at
O	147	156	diagnosis
O	157	166	increases
O	167	170	the
O	171	175	risk
O	176	178	of
B-Symptom	179	186	central
I-Symptom	187	193	vision
I-Symptom	194	198	loss
O	199	202	and
B-Symptom	203	211	glaucoma
I-Symptom	212	221	blindness
O	221	222	.

O	223	236	Retrospective
O	237	243	cohort
O	244	249	study
O	249	250	.

O	251	252	A
O	253	258	total
O	259	261	of
O	262	265	309
O	266	274	patients
O	275	276	(
O	276	279	309
B-Anatomy	280	284	eyes
O	284	285	)
O	286	290	with
B-Disease	291	299	glaucoma
O	300	304	were
O	305	313	followed
O	314	316	up
O	317	322	until
O	323	328	death
O	328	329	;
O	330	333	203
O	334	342	patients
O	343	344	(
O	344	346	65
O	346	347	.
O	347	348	7
O	348	349	%
O	349	350	)
O	351	354	had
B-Disease	355	362	primary
I-Disease	363	367	open
I-Disease	367	368	-
I-Disease	368	373	angle
I-Disease	374	382	glaucoma
O	382	383	,
O	384	387	and
O	388	391	106
O	392	400	patients
O	401	402	(
O	402	404	34
O	404	405	.
O	405	406	2
O	406	407	%
O	407	408	)
O	409	412	had
B-Disease	413	424	exfoliation
I-Disease	425	433	glaucoma
O	433	434	.

O	435	440	Study
B-Anatomy	441	445	eyes
O	446	450	were
O	451	458	divided
O	459	463	into
O	464	465	2
O	466	472	groups
O	473	482	according
O	483	485	to
B-Symptom	486	489	TTF
O	490	492	in
O	493	496	the
O	497	502	first
B-Disease	503	515	glaucomatous
O	516	522	visual
O	523	528	field
O	528	529	:
O	530	531	(
O	531	532	1
O	532	533	)
B-Anatomy	534	538	eyes
O	539	543	with
B-Symptom	544	547	TTF
O	547	548	,
O	549	556	defined
O	557	559	as
B-Symptom	560	566	visual
I-Symptom	567	572	field
I-Symptom	573	577	loss
O	578	579	(
B-Symptom	579	582	VFL
O	582	583	)
O	584	593	including
O	594	595	≥
O	595	596	1
O	597	599	of
O	600	603	the
O	604	605	4
O	606	615	innermost
O	616	622	points
O	623	632	depressed
O	633	635	at
O	636	637	P
O	639	640	<
O	642	643	1
O	643	644	%
O	645	650	level
O	651	653	in
O	654	656	24
O	656	657	-
O	657	658	2
O	659	661	or
O	662	664	30
O	664	665	-
O	665	666	2
O	667	675	Humphrey
O	676	682	fields
O	682	683	;
O	684	685	(
O	685	686	2
O	686	687	)
B-Anatomy	688	692	eyes
O	693	700	without
B-Symptom	701	704	TTF
O	704	705	,
O	706	713	defined
O	714	716	as
B-Symptom	717	720	VFL
O	721	725	only
O	726	733	outside
O	734	737	the
O	738	739	4
O	740	749	innermost
O	750	756	points
O	756	757	.

O	758	766	Lifetime
O	767	771	risk
O	772	774	of
B-Symptom	775	781	visual
I-Symptom	782	788	acuity
I-Symptom	789	790	(
I-Symptom	790	792	VA
I-Symptom	792	793	)
I-Symptom	794	798	loss
O	799	802	and
B-Symptom	803	811	glaucoma
I-Symptom	812	821	blindness
O	822	824	in
O	825	828	the
O	829	830	2
O	831	837	groups
O	838	841	was
O	842	850	compared
O	851	853	by
O	854	862	logistic
O	863	873	regression
O	874	882	analysis
O	882	883	.

O	884	885	A
O	886	894	matching
O	895	904	technique
O	905	908	was
O	909	913	used
O	914	916	to
O	917	923	adjust
O	924	927	for
O	928	939	differences
O	940	942	in
O	943	950	disease
O	951	956	stage
O	957	959	at
O	960	972	presentation
O	972	973	.

O	974	977	The
O	978	986	relative
O	987	996	influence
O	997	999	of
B-Symptom	1000	1003	TTF
O	1004	1006	on
O	1007	1010	the
O	1011	1015	risk
O	1016	1018	of
B-Symptom	1019	1028	blindness
O	1029	1031	in
O	1032	1035	the
O	1036	1037	2
O	1038	1045	matched
O	1046	1052	groups
O	1053	1056	was
O	1057	1065	analyzed
O	1066	1068	by
O	1069	1072	the
O	1073	1079	Kaplan
O	1079	1080	-
O	1080	1085	Meier
O	1086	1092	method
O	1092	1093	.

B-Symptom	1094	1100	Visual
I-Symptom	1101	1107	acuity
I-Symptom	1109	1110	<
I-Symptom	1111	1112	0
I-Symptom	1112	1113	.
I-Symptom	1113	1114	3
O	1115	1118	and
B-Symptom	1119	1128	blindness
O	1129	1133	from
B-Disease	1134	1142	glaucoma
O	1143	1144	(
O	1144	1149	World
O	1150	1156	Health
O	1157	1169	Organization
O	1170	1178	criteria
O	1178	1179	)
O	1180	1182	at
O	1183	1187	last
O	1188	1193	visit
O	1193	1194	.

B-Symptom	1195	1201	Threat
I-Symptom	1202	1204	to
I-Symptom	1205	1213	fixation
O	1214	1217	was
O	1218	1226	detected
O	1227	1229	in
O	1230	1232	58
O	1232	1233	.
O	1233	1234	9
O	1234	1235	%
O	1236	1238	of
O	1239	1242	the
B-Anatomy	1243	1247	eyes
O	1248	1250	at
O	1251	1260	diagnosis
O	1260	1261	.

O	1262	1265	The
O	1266	1275	frequency
O	1276	1278	of
B-Symptom	1279	1282	TTF
O	1283	1292	increased
O	1293	1297	with
O	1298	1303	stage
O	1304	1306	of
B-Symptom	1307	1319	glaucomatous
I-Symptom	1320	1324	loss
O	1324	1325	:
O	1326	1328	28
O	1328	1329	.
O	1329	1330	3
O	1330	1331	%
O	1332	1334	in
B-Anatomy	1335	1339	eyes
O	1340	1344	with
O	1345	1349	mean
O	1350	1359	deviation
O	1360	1361	(
O	1361	1363	MD
O	1363	1364	)
O	1366	1367	>
O	1368	1369	-
O	1369	1370	6
O	1370	1371	.
O	1371	1373	00
O	1374	1382	decibels
O	1383	1384	(
O	1384	1386	dB
O	1386	1387	)
O	1388	1394	versus
O	1395	1397	95
O	1397	1398	.
O	1398	1399	7
O	1399	1400	%
O	1401	1405	with
O	1406	1408	MD
O	1410	1411	<
O	1412	1413	-
O	1413	1415	20
O	1415	1416	.
O	1416	1418	00
O	1419	1421	dB
O	1421	1422	.

O	1423	1433	Univariate
O	1434	1442	analysis
O	1443	1455	demonstrated
O	1456	1460	that
B-Anatomy	1461	1465	eyes
O	1466	1470	with
B-Symptom	1471	1474	TTF
O	1475	1477	at
O	1478	1490	presentation
O	1491	1499	compared
O	1500	1504	with
B-Anatomy	1505	1509	eyes
O	1510	1517	without
B-Symptom	1518	1521	TTF
O	1522	1528	became
B-Symptom	1529	1534	blind
O	1535	1539	more
O	1540	1545	often
O	1546	1547	(
O	1547	1549	56
O	1549	1550	/
O	1550	1553	182
O	1554	1555	[
O	1555	1557	30
O	1557	1558	.
O	1558	1559	8
O	1559	1560	%
O	1560	1561	]
O	1562	1564	vs
O	1564	1565	.
O	1566	1568	22
O	1568	1569	/
O	1569	1572	127
O	1573	1574	[
O	1574	1576	17
O	1576	1577	.
O	1577	1578	3
O	1578	1579	%
O	1579	1580	]
O	1581	1582	;
O	1583	1584	P
O	1585	1586	=
O	1587	1588	0
O	1588	1589	.
O	1589	1592	008
O	1592	1593	)
O	1594	1597	and
O	1598	1604	faster
O	1605	1606	(
O	1606	1610	mean
O	1611	1615	time
O	1616	1620	from
O	1621	1630	diagnosis
O	1631	1633	to
B-Symptom	1634	1643	blindness
O	1643	1644	,
O	1645	1647	84
O	1647	1648	.
O	1648	1649	6
O	1649	1650	±
O	1650	1652	50
O	1652	1653	.
O	1653	1654	7
O	1655	1657	vs
O	1657	1658	.
O	1659	1662	126
O	1662	1663	.
O	1663	1664	7
O	1664	1665	±
O	1665	1667	51
O	1667	1668	.
O	1668	1669	4
O	1670	1676	months
O	1676	1677	;
O	1678	1679	P
O	1681	1682	<
O	1684	1685	0
O	1685	1686	.
O	1686	1689	002
O	1689	1690	)
O	1690	1691	.

O	1692	1699	However
O	1699	1700	,
O	1701	1703	in
O	1704	1716	multivariate
O	1717	1725	analysis
O	1725	1726	,
B-Symptom	1727	1730	TTF
O	1731	1734	was
O	1735	1738	not
O	1739	1741	an
O	1742	1753	independent
O	1754	1758	risk
O	1759	1765	factor
O	1766	1769	for
B-Symptom	1770	1772	VA
I-Symptom	1774	1775	<
I-Symptom	1776	1777	0
I-Symptom	1777	1778	.
I-Symptom	1778	1779	3
O	1780	1781	(
O	1781	1785	odds
O	1786	1791	ratio
O	1791	1792	,
O	1793	1794	1
O	1794	1795	.
O	1795	1797	43
O	1797	1798	;
O	1799	1801	95
O	1801	1802	%
O	1803	1813	confidence
O	1814	1822	interval
O	1822	1823	,
O	1824	1825	0
O	1825	1826	.
O	1826	1828	75
O	1828	1829	-
O	1829	1830	2
O	1830	1831	.
O	1831	1833	74
O	1833	1834	)
O	1835	1837	or
B-Symptom	1838	1847	blindness
O	1848	1849	(
O	1849	1853	odds
O	1854	1859	ratio
O	1859	1860	,
O	1861	1862	1
O	1862	1863	.
O	1863	1865	03
O	1865	1866	;
O	1867	1869	95
O	1869	1870	%
O	1871	1881	confidence
O	1882	1890	interval
O	1890	1891	,
O	1892	1893	0
O	1893	1894	.
O	1894	1896	52
O	1896	1897	-
O	1897	1898	2
O	1898	1899	.
O	1899	1901	01
O	1901	1902	)
O	1902	1903	.

O	1904	1908	With
O	1909	1915	regard
O	1916	1918	to
O	1919	1926	patient
O	1927	1935	survival
O	1936	1940	time
O	1940	1941	,
O	1942	1947	there
O	1948	1952	were
O	1953	1955	no
O	1956	1967	differences
O	1968	1975	between
B-Anatomy	1976	1980	eyes
O	1981	1985	with
B-Symptom	1986	1989	TTF
O	1990	1993	and
B-Anatomy	1994	1998	eyes
O	1999	2006	without
B-Symptom	2007	2010	TTF
O	2011	2016	after
O	2017	2026	adjusting
O	2027	2030	for
O	2031	2042	disparities
O	2043	2045	in
O	2046	2053	disease
O	2054	2062	severity
O	2063	2065	at
O	2066	2078	presentation
O	2079	2080	(
O	2080	2081	P
O	2082	2083	=
O	2084	2085	0
O	2085	2086	.
O	2086	2089	934
O	2089	2090	)
O	2090	2091	.

O	2092	2101	Including
B-Symptom	2102	2105	TTF
O	2106	2108	in
O	2109	2112	the
O	2113	2123	assessment
O	2124	2126	of
O	2127	2131	risk
O	2132	2135	for
B-Symptom	2136	2144	glaucoma
I-Symptom	2145	2154	blindness
O	2155	2158	did
O	2159	2162	not
O	2163	2166	add
O	2167	2170	any
O	2171	2180	important
O	2181	2192	information
O	2193	2197	when
O	2198	2201	the
O	2202	2207	stage
O	2208	2210	of
B-Symptom	2211	2214	VFL
O	2215	2218	was
O	2219	2224	taken
O	2225	2229	into
O	2230	2237	account
O	2237	2238	.
